Jefferies Group's AZN Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 186,676 shares of AstraZeneca PLC (AZN) worth $34.89 M, representing 0.23% of the portfolio. First purchased in 2022-Q4, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in AZN, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 171,888 shares. Largest reduction occurred in Q3 2023, reducing 14,063 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's AstraZeneca PLC (AZN) Holding Value Over Time
Track share changes against reported price movement
Quarterly AstraZeneca PLC (AZN) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +171,888 | Add 1162.35% | 186,676 | $186.89 |
| Q1 2026 | +10,800 | Add 270.81% | 14,788 | $194.43 |
| Q4 2025 | +3,988 | New Buy | 3,988 | $183.86 |
| Q2 2025 | -3,148 | Sold Out | 0 | $0.00 |
| Q1 2025 | +3,148 | New Buy | 3,148 | $147.00 |
| Q4 2024 | -1,304 | Sold Out | 0 | $0.00 |
| Q3 2024 | +1,304 | New Buy | 1,304 | $155.76 |
| Q1 2024 | -1,850 | Sold Out | 0 | $0.00 |
| Q4 2023 | -4,135 | Reduce 69.09% | 1,850 | $134.70 |
| Q3 2023 | -14,063 | Reduce 70.15% | 5,985 | $135.44 |
| Q2 2023 | +2,082 | Add 11.59% | 20,048 | $143.14 |
| Q1 2023 | -194 | Reduce 1.07% | 17,966 | $138.82 |
| Q4 2022 | +18,160 | New Buy | 18,160 | $135.60 |
Jefferies Group's AstraZeneca PLC Investment FAQs
Jefferies Group first purchased AstraZeneca PLC (AZN) in Q4 2022, acquiring 18,160 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held AstraZeneca PLC (AZN) for 13 quarters since Q4 2022.
Jefferies Group's largest addition to AstraZeneca PLC (AZN) was in Q2 2026, adding 186,676 shares worth $34.89 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 186,676 shares of AstraZeneca PLC (AZN), valued at approximately $34.89 M.
As of the Q2 2026 filing, AstraZeneca PLC (AZN) represents approximately 0.23% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in AstraZeneca PLC (AZN) was 186,676 shares, as reported at the end of Q2 2026.